Nicholas D’Cunha

508 total citations
32 papers, 282 citations indexed

About

Nicholas D’Cunha is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Nicholas D’Cunha has authored 32 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Genetics and 10 papers in Hematology. Recurrent topics in Nicholas D’Cunha's work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Cancer Treatment and Pharmacology (6 papers). Nicholas D’Cunha is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Cancer Treatment and Pharmacology (6 papers). Nicholas D’Cunha collaborates with scholars based in United States, United Kingdom and Ireland. Nicholas D’Cunha's co-authors include Everardo Cobos, Maurizio Chiriva‐Internati, W. Martin Kast, Fred Hardwicke, Fabio Grizzi, Leonardo Mirandola, Yuefei Yu, Eldo E. Frezza, Pier Carlo Muzzio and Marjorie Jenkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicholas D’Cunha

29 papers receiving 275 citations

Peers

Nicholas D’Cunha

ONCOL

IMMUN

HEMAT

PRM

Micaela Harrasser United Kingdom

Kieran Adam United States

David Sermer United States

Saada Eid United States

Jianquan Hou China

Oliver Stötzer Germany

Alessandro Previtali United States

Stefanie Bugl Germany

Qingsong Yin China

Grégoire Berthod Switzerland

Micaela Harrasser United Kingdom

Nicholas D’Cunha

116 ×0.8

ONCOL

130 ×1.3

IMMUN

71 ×0.8

58 ×1.2

HEMAT

34 ×0.9

PRM

Citations per year, relative to Nicholas D’Cunha Nicholas D’Cunha (= 1×) peers Micaela Harrasser

Countries citing papers authored by Nicholas D’Cunha

Since Specialization

Citations

This map shows the geographic impact of Nicholas D’Cunha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas D’Cunha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas D’Cunha more than expected).

Fields of papers citing papers by Nicholas D’Cunha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas D’Cunha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas D’Cunha. The network helps show where Nicholas D’Cunha may publish in the future.

Co-authorship network of co-authors of Nicholas D’Cunha

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas D’Cunha. A scholar is included among the top collaborators of Nicholas D’Cunha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas D’Cunha. Nicholas D’Cunha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thein, Kyaw Zin, Nusrat Jahan, Ahmed Sultan, et al.. (2019). MA03.07 First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations. Journal of Thoracic Oncology. 14(10). S259–S259.

Tun, Aung M., et al.. (2019). Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab. Blood. 134(Supplement_1). 4771–4771. 5 indexed citations

Thein, Kyaw Zin, et al.. (2019). 1423 Primary B-Cell Pancreatic Lymphoma Presenting as Acute Pancreatitis. The American Journal of Gastroenterology. 114(1). S791–S791. 2 indexed citations

Sultan, Ahmed, et al.. (2019). Treatment-related adverse events and tolerability in patients with advanced non-squamous non-small cell lung cancer treated with first-line checkpoint inhibitors in combination with chemotherapy. Annals of Oncology. 30. v729–v729. 1 indexed citations

Kopel, Jonathan, et al.. (2019). Risk of Serious Adverse Events, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Treated with Idelalisib. Blood. 134(Supplement_1). 5489–5489. 2 indexed citations

Thein, Kyaw Zin, Ahmed Sultan, Carolyn Jones, et al.. (2018). Risk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance. Annals of Oncology. 29. viii627–viii628. 1 indexed citations

D’Cunha, Nicholas, et al.. (2017). Monomorphic Cutaneous T-Cell Lymphoma in a Patient with Cadaveric Renal Transplant on Immunosuppressive Drugs and Renal Impairment Treated Successfully with Single Agent Brentuximab Vedotin. Blood. 130. 5190–5190.

Figueroa, José A., Leonardo Mirandola, Alejandro Figueroa, et al.. (2015). Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy. International Reviews of Immunology. 34(2). 154–187. 64 indexed citations

Verma, Rashmi, Leonardo Mirandola, José A. Figueroa, et al.. (2014). Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer.. Journal of Clinical Oncology. 32(15_suppl). e22005–e22005. 1 indexed citations

10.

Verma, Rashmi, Leonardo Mirandola, José A. Figueroa, et al.. (2014). Effect of the novel galectin-3 blocker, Gal3M, on the efficacy and reduction of toxicity of proteasome inhibitors for the treatment of multiple myeloma.. Journal of Clinical Oncology. 32(15_suppl). e19581–e19581. 9 indexed citations

11.

Sutamtewagul, Grerk, et al.. (2013). Reactive Thrombocytosis Associated with Acute Myocardial Infarction following STEMI with Percutaneous Coronary Intervention. SHILAP Revista de lepidopterología. 2013. 1–3. 8 indexed citations

12.

Jenkins, Marjorie, Maurizio Chiriva‐Internati, Leonardo Mirandola, et al.. (2012). Perspective for Prophylaxis and Treatment of Cervical Cancer: An Immunological Approach. International Reviews of Immunology. 31(1). 3–21. 7 indexed citations

13.

Radhi, Saba, Raed Alalawi, Leonardo Mirandola, et al.. (2012). Novel tumor markers in non-small cell lung cancer detected both in serology and tissue.. Journal of Clinical Oncology. 30(15_suppl). e21105–e21105. 2 indexed citations

14.

Chiriva‐Internati, Maurizio, Yuefei Yu, Leonardo Mirandola, et al.. (2011). Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. The Prostate. 72(1). 12–23. 40 indexed citations

15.

Wang, Li, Lynn T. Frame, Karlene A. Hoo, et al.. (2011). Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cellsin vitro. Leukemia & lymphoma. 52(12). 2380–2390. 18 indexed citations

16.

Islam, Sameer, Sreeram Parupudi, Ebtesam Islam, et al.. (2009). Sigmoid plasmacytoma mimicking colon cancer in a patient with multiple myeloma: case report and review of literature. Gastrointestinal Endoscopy. 71(3). 655–657. 11 indexed citations

17.

Chiriva‐Internati, Maurizio, Raffaele Ferrari, Yuefei Yu, et al.. (2008). The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma. Journal of Translational Medicine. 6(1). 15–15. 14 indexed citations

18.

Ferrari, Raffaele, Yifan Yu, Juan Carlos Alvarez Moreno, et al.. (2008). AKAP-4 as biomarker for prostate cancer. 56(1). 394–394.

19.

Chiriva‐Internati, Maurizio, Fabio Grizzi, K. John Morrow, et al.. (2006). GAMMA-RADIATION UPREGULATES MHC CLASS I/II AND ICAM-I MOLECULES IN MULTIPLE MYELOMA CELL LINES AND PRIMARY TUMORS. In Vitro Cellular & Developmental Biology - Animal. 42(3). 89–89. 51 indexed citations

20.

Chiriva‐Internati, Maurizio, Fabio Grizzi, Nicholas D’Cunha, et al.. (2006). Gamma-radiation up-regulates MHC Class I/II and ICAM-I molecules in Multiple Myeloma cell lines and primary tumors. In Vitro Cellular & Developmental Biology - Animal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact